A Practical Approach to Retinal Dystrophies.

Area of Science:

• Ophthalmology
• Genetics
• Molecular Biology

Background:

• Retinal dystrophies were historically considered untreatable, but advancements in genetic understanding have changed this outlook.
• Accurate diagnosis and prognosis are crucial for managing retinal dystrophies effectively.

Purpose of the Study:

• To highlight the advancements in genomic approaches for diagnosing and treating retinal dystrophies.
• To emphasize the importance of integrated diagnostic methods and emerging gene therapies.

Main Methods:

• Utilizing electrophysiological testing and autofluorescence imaging for diagnosis and disease prediction.
• Employing fundoscopy, autofluorescent imaging, and electrophysiological testing for comprehensive patient assessment.
• Leveraging genomic sequencing for precise genotyping to guide targeted therapies.

Main Results:

• Genomic strategies are providing novel diagnostic and therapeutic avenues for retinal dystrophies.
• The development of targeted gene therapies, such as Voretigene Neparvovec, offers new hope for patients.
• Improved phenotyping enhances the efficiency and cost-effectiveness of genetic testing.

Conclusions:

• The paradigm for retinal dystrophy treatment has shifted from palliative care to active intervention.
• Integrated diagnostic approaches combined with gene-based therapies represent the future of retinal dystrophy management.
• Ongoing research promises further breakthroughs in treating these debilitating conditions.